NCT03075800: ACT+IMR

Integration of Illness Management and Recovery Within ACT

Completed NA Last updated 9 March 2017

What this trial tests

NA trial testing Assertive Community Treatment (ACT) + Illness Management and Recovery (IMR) in Severe Mental Illness in 101 participants. Completed in 31 March 2015.

Timeline

7 June 2011

Primary endpoint
31 March 2015

31 March 2015

Quick facts

Lead sponsor	University of Washington
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	101
Start date	7 June 2011
Primary completion	31 March 2015
Estimated completion	31 March 2015

Drugs / interventions tested

• Assertive Community Treatment (ACT) + Illness Management and Recovery (IMR)

Conditions studied

• Severe Mental Illness — all drugs for Severe Mental Illness →
• Schizophrenia — all drugs for Schizophrenia →
• Bipolar Disorder — all drugs for Bipolar Disorder →

Sponsor

University of Washington

Who can join

Adults 23 to 69, any sex, with Severe Mental Illness or Schizophrenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Integrating Illness Management and Recovery (IMR) into Assertive Community Treatment (ACT) has great promise for improving the symptomatic, functional, and recovery outcomes for people with Serious Mental Illness (SMI), especially those individuals who have the greatest needs. In addition to these positive consumer outcomes, system benefits may also accrue due to more rapid graduation of consumers from ACT (with IMR) programs to less intensive levels of care. However, before these benefits can be realized, research and development are needed to design and pilot test a treatment manual that is feasible and acceptable to consumers and staff for integrating IMR and ACT.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.